KODNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Kodiak Sciences Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$91.35+5.60 (+6.53%)
Close on Oct 19, 2026
- Market cap
- $5.72B
- P/E (TTM)
- –
- Dividend yield
- –